Automation Meets Cell Separation: Primary Cell Isolation for Immuno-oncology Assays
Lotta Raety, Group Leader, Product Manager, Cell Separation, Global Marketing, Miltenyi Biotec B.V. & Co. KG
Whether you are performing killing assays, characterizing the tumor microenvironment, or investigating immunogenicity,
primary cells are essential for the discovery of new immuno-oncology therapeutics. Conclusive assay results depend on reliable sample preparation, including Ficoll-free cell separation and efficient tumor dissociation. We have developed cell isolation
solutions from various starting materials to ensure the best fit for every drug discovery program - join us to learn about the best methods for your in vitro assays.